On April 24, 2023 Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, reported that it will host a conference call on May 4, 2023, at 4:30 PM Eastern Time to discuss results for its first quarter ended March 31, 2023 (Press release, Panbela Therapeutics, APR 24, 2023, View Source;utm_medium=rss&utm_campaign=panbela-to-host-first-quarter-2023-earnings-conference-call-on-may-4-2023 [SID1234630442]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Conference Call Information

To participate in this event, dial approximately 5 to 10 minutes before the beginning of the call.
Date: Thursday, May 04, 2023
Time: 4:30 PM Eastern Time
Participant Numbers: Toll Free: 888-506-0062; Code: 130038
International: 973-528-0011; Code: 130038
Webcast: View Source

Conference Call Replay Information
Toll Free: 877-481-4010 International: 919-882-2331 Replay Passcode: 47950
Webcast replay: View Source